13F Data
13F filer · CIK 1388551

CAXTON CORP

Princeton, NJ · filing since Q2 2013 · last filing Aug 14, 2026
Reported value
$1.9M
$-2.2M vs prior
Positions
10
New / sold out
4 / 1
Added / reduced
2 / 1
Turnover
38.8%
buys $1.1M · sells $3.3M
Top-10 weight
100.0%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
NewSPACE EXPLORATION TECHN CORP+2,606–+$445.3K
NewALPHABET INC+691–+$246.9K
NewVANGUARD INDEX FDS+339–+$233.1K
NewBLACKSTONE INC+1,597–+$188.2K
AddedLEXEO THERAPEUTICS INC+3,019+21.7%+$14.1K
AddedBERKSHIRE HATHAWAY INC DEL+27+3.7%+$13.5K

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outSPDR GOLD TR-7,623-100.0%$-3.3M
ReducedKYVERNA THERAPEUTICS INC-6,426-34.2%$-57.3K

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q2 2013: $118.2MQ3 2013: $149.3MQ4 2013: $157.5MQ1 2014: $131.0MQ2 2014: $129.7MQ3 2014: $97.2MQ4 2014: $86.9MQ1 2015: $83.8MQ2 2015: $94.5MQ3 2015: $74.1MQ4 2015: $23.8MQ1 2016: $72.5MQ2 2016: $88.6MQ3 2016: $22.3MQ4 2016: $29.3MQ1 2017: $35.0MQ2 2017: $64.1MQ3 2017: $98.2MQ4 2017: $82.3MQ1 2018: $92.1MQ2 2018: $283.0MQ3 2018: $108.2MQ4 2018: $82.4MQ1 2019: $107.8MQ2 2019: $88.0MQ3 2019: $88.7MQ4 2019: $103.7MQ1 2020: $91.5MQ2 2020: $94.7MQ3 2020: $106.1MQ4 2020: $160.4MQ1 2021: $153.9MQ2 2021: $146.0MQ3 2021: $123.4MQ4 2021: $122.3MQ1 2022: $80.4MQ2 2022: $74.4MQ3 2022: $53.2MQ4 2022: $39.1MQ1 2023: $39.6MQ2 2023: $34.7MQ3 2023: $26.3MQ4 2023: $18.5MQ1 2024: $17.6MQ2 2024: $19.7MQ3 2024: $24.2MQ4 2024: $16.6MQ1 2025: $5.1MQ2 2025: $9.9MQ3 2025: $22.9MQ4 2025: $4.3MQ1 2026: $4.0MQ2 2026: $1.9M
Q2 2013Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1SPACE EXPLORATION TECHN CORPPUT2,606$445.3K24.03%
2BERKSHIRE HATHAWAY INC DELCL B NEW754$377.1K20.35%
3ALPHABET INCCAP STK CL A691$246.9K13.32%
4VANGUARD INDEX FDSS&P 500 ETF SHS339$233.1K12.58%
5BLACKSTONE INCCOM1,597$188.2K10.16%
6KYVERNA THERAPEUTICS INCCOM12,347$110.0K5.94%
7LEXEO THERAPEUTICS INCCOM16,962$79.0K4.26%
8X4 PHARMACEUTICALS INCCOM NEW15,557$72.7K3.92%
9INHIBIKASE THERAPEUTICS INCCOM NEW28,453$57.8K3.12%
10ALX ONCOLOGY HLDGS INCCOM20,946$43.4K2.34%